Red Door Wealth Management’s GSK GSK Stock Holding History

Red Door Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$220K	Buy	+4,193	New	+$222K	0.02%	298
2022 Q3	–	Sell	-8,458	Closed	-$460K	–	133
2022 Q2	$460K	Sell	8,458 -332	-4%	-$18.3K	0.17%	88
2022 Q1	$478K	Sell	8,790 -208	-2%	-$11.3K	0.16%	88
2021 Q4	$496K	Buy	8,998 +19	+0.2%	+$988	0.16%	94
2021 Q3	$429K	Sell	8,979 -399	-4%	-$20K	0.16%	98
2021 Q2	$466K	Sell	9,378 -1,172	-11%	-$56.3K	0.18%	92
2021 Q1	$471K	Buy	10,550 +32	+0.3%	+$1.45K	0.24%	81
2020 Q4	$484K	Buy	10,518 +144	+1%	+$6.62K	0.29%	72
2020 Q3	$489K	Sell	10,374 -127	-1%	-$6.36K	0.36%	68
2020 Q2	$535K	Sell	10,501 -1,902	-15%	-$97.6K	0.39%	64
2020 Q1	$587K	Sell	12,403 -592	-5%	-$31.6K	0.56%	46
2019 Q4	$764K	Buy	+12,995	New	+$723K	0.68%	46

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Red Door Wealth Management's GSK Position: Q2 2026 in Review

Red Door Wealth Management opened a new position in GSK (GSK) in Q2 2026: 4,193 shares worth $220K. The stake represents 0.02% of the portfolio and ranks #298 among its holdings. This is a return to the name: Red Door Wealth Management previously reported a position in GSK as recently as Q2 2022.

Red Door Wealth Management first reported a position in GSK in Q4 2019 and has held it in 12 quarters since. The position peaked at $764K in Q4 2019. 1,042 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Red Door Wealth Management held 4,193 shares of GSK worth $220K as of Q2 2026.
GSK was a new Red Door Wealth Management position in Q2 2026.
GSK made up 0.02% of Red Door Wealth Management's portfolio in Q2 2026, its #298 holding.
Red Door Wealth Management first reported a position in GSK in Q4 2019 and has held it in 12 quarters since.
Red Door Wealth Management's GSK position peaked at $764K in Q4 2019.
1,042 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.